194 related articles for article (PubMed ID: 23775735)
1. Thoracic organ transplantation: laboratory methods.
Patel JK; Kobashigawa JA
Methods Mol Biol; 2013; 1034():127-43. PubMed ID: 23775735
[TBL] [Abstract][Full Text] [Related]
2. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
4. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
Reinsmoen NL; Nelson K; Zeevi A
Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
6. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
7. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
8. Annual literature review of donor-specific HLA antibodies after organ transplantation.
Kaneku H
Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
[TBL] [Abstract][Full Text] [Related]
9. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
10. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
[TBL] [Abstract][Full Text] [Related]
11. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
12. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation.
Campbell P
Curr Opin Organ Transplant; 2013 Aug; 18(4):463-9. PubMed ID: 23838652
[TBL] [Abstract][Full Text] [Related]
16. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
18. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.
Everly MJ
Clin Transpl; 2011; ():319-25. PubMed ID: 22755425
[TBL] [Abstract][Full Text] [Related]
19. The role of the histocompatibility laboratory in desensitization for transplantation.
Leffell MS; Zachary AA
Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
[TBL] [Abstract][Full Text] [Related]
20. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
